SLC1A2 and Alzheimer disease: In human postmortem AD brain tissue, the expression of intact EAAT2 is decreased in the brain regions susceptible to AD pathology, but the level of a pathology-specific alternative splice variant of EAAT2 is increased (Scott et al., 2011).